drugset / Trial / NCT03421275

Intranasal Esketamine and Fentanyl for Pain in Minor Trauma

NCT03421275

Phase 4 Unknown 105 enrolled Anna Meuronen, MD
RandomizedParallel-groupTriple-blindTreatment

Summary

Intranasal esketamine, fentanyl and placebo are compared in treatment of acute pain in adult patients with minor trauma. Study is blinded randomized placebo-controlled parallel design.

Timeline

Start
2017-12-01
Primary completion
2022-12-01
Completion
2022-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Esketamine Other / unclassified Intranasal
Comparator Fentanyl Other / unclassified Intranasal

Indications

No indication recorded.